MarketCap
Facebook
X
Telegram
Aptorum Group Limited Cash Conversion Cycle | APM
Annual Cash Conversion Cycle Aptorum Group Limited
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -2.57 K | -897 | -400 | 20.6 | 14.8 | 1.35 | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 | -2.57 K | -638 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Crinetics Pharmaceuticals
CRNX
|
-4.27 K | $ 84.95 | 0.13 % | $ 7.99 B |  USA |
 |
GeoVax Labs
GOVX
|
48.4 | $ 2.13 | -20.4 % | $ 2.04 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
-284 | - | - | $ 521 M | USA |
 |
Seelos Therapeutics
SEEL
|
63.2 | - | -47.76 % | $ 6.27 M | USA |
 |
Celldex Therapeutics
CLDX
|
-307 | $ 30.18 | -1.53 % | $ 2 B | USA |
 |
Moderna
MRNA
|
-44.1 | $ 248.62 | -0.88 % | $ 96.7 B | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-90.5 | $ 3.96 | 1.41 % | $ 48.3 M |  Israel |
 |
Nektar Therapeutics
NKTR
|
-29.3 | $ 38.41 | 1.67 % | $ 648 M | USA |
 |
CorMedix
CRMD
|
359 | $ 5.31 | -2.23 % | $ 383 K | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
-9.73 | $ 1.66 | -2.64 % | $ 1.12 B | Israel |
 |
Deciphera Pharmaceuticals
DCPH
|
-101 | - | - | $ 2.18 B | USA |
 |
Idera Pharmaceuticals
IDRA
|
158 | - | -23.04 % | $ 26.6 M | USA |
 |
Verona Pharma plc
VRNA
|
136 | - | - | $ 69.7 B |  Britain |
 |
Oramed Pharmaceuticals
ORMP
|
-113 | $ 4.1 | 3.27 % | $ 170 M | Israel |
 |
Karuna Therapeutics
KRTX
|
15.9 | - | - | $ 12.2 B | USA |
 |
Curis
CRIS
|
64.7 | $ 0.59 | -9.62 % | $ 7.77 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
137 | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Fusion Pharmaceuticals
FUSN
|
6 | - | - | $ 1.41 B |  Canada |
 |
Завод ДИОД
DIOD
|
-32.7 | - | - | - |  Russia |
 |
Gritstone Oncology
GRTS
|
40.3 | - | 0.42 % | $ 213 M | USA |
 |
Pfizer
PFE
|
189 | $ 29.42 | 0.19 % | $ 167 B | USA |
 |
HOOKIPA Pharma
HOOK
|
3.33 | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
160 | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
84.9 | - | - | $ 109 M | USA |
 |
Otonomy
OTIC
|
-844 | - | -1.96 % | $ 4.68 M | USA |
 |
Prothena Corporation plc
PRTA
|
6.97 | $ 8.74 | 2.1 % | $ 470 M | USA |
 |
Exelixis
EXEL
|
-8.32 | $ 70.73 | 0.21 % | $ 19.2 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | USA |
 |
Фармсинтез
LIFE
|
-15.9 | - | - | - | Russia |
 |
Dr. Reddy's Laboratories Limited
RDY
|
230 | $ 14.79 | -0.57 % | $ 12.3 B |  India |
 |
Oncternal Therapeutics
ONCT
|
-345 | - | -24.12 % | $ 1.56 M | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
213 | $ 114.06 | 0.1 % | $ 7.41 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
126 | - | - | $ 26.5 M | USA |
 |
SIGA Technologies
SIGA
|
640 | $ 3.17 | 0.32 % | $ 227 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
5.06 | - | - | $ 401 M | USA |